Streetbeat News

Stock Prices

SLNO

Trading of Soleno Therapeutics shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:42 pm

LYFT

LYFT shares are trading higher after BTIG noted a healthy trend in 3Q rides and increased its forecast for 2024 numbers.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:42 pm

FEMY

Shares of Femasys Inc. (FEMY) were halted twice due to circuit breakers, once after resuming trade and then again as the stock surged 227%.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:39 pm

SLNO

Shares of Soleno Therapeutics (SLNO) were halted on a circuit breaker to the upside, with the stock now up 383.1%.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:35 pm

AVTX

Avalo Therapeutics has announced the payoff of the remainder of its $35 million debt owed to Horizon Technology Finance. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:34 pm

IMVT

ROIV

Immunovant Inc (NASDAQ:IMVT), a unit of Roivant Sciences Ltd (NASDAQ:ROIV), announced positive initial data from a Phase 1 trial of IMVT-1402, showing dose-dependent reductions in Immunoglobulin G (IgG) in healthy adults. The safety data were generally favorable, with all adverse events mild or moderate. Following the news, ROIV shares are up 18.50% and IMVT stock is up 70.70%.

Portfolio Pulse from Vandana Singh

September 26, 2023 | 1:33 pm

BTCUSD

ETHUSD

MKRUSD

RNDRUSD

Bitcoin and Ethereum traded higher, with Bitcoin close to the $26,300 level and Ethereum below the key $1,600 mark. Maker was the top gainer over the prior 24 hours, while Render was the biggest loser. The global crypto market cap rose to $1.05 trillion, recording a 24-hour gain of 0.5%.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 1:32 pm

FEMY

Shares of Femasys Inc. (FEMY) were halted on a circuit breaker due to a significant increase in the stock price. The stock is now up by 304.1%.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:32 pm

STSS

Sharps Technology has signed a $50 million asset purchase agreement to acquire Nephron's InjectEZ syringe manufacturing facility. This has led to an increase in Sharps Technology's share price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 1:32 pm

ICPT

Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ:ICPT) for $19.00 per share in cash, a premium of 82% to Intercept's closing stock price on September 25, 2023. The acquisition will expand Alfasigma's gastrointestinal and hepatology portfolio and its presence in the U.S. market. The transaction is expected to close by the end of 2023, after which Intercept's common stock will no longer be publicly listed.

Portfolio Pulse from Vandana Singh

September 26, 2023 | 1:30 pm